172 related articles for article (PubMed ID: 32650210)
1. Comparative epidemiology of gliosarcoma and glioblastoma and the impact of Race on overall survival: A systematic literature review.
Gerges C; Elder T; Penuela M; Rossetti N; Maynard M; Jeong S; Wright CH; Wright J; Zhou X; Burant C; Sajatovic M; Hodges T
Clin Neurol Neurosurg; 2020 Aug; 195():106054. PubMed ID: 32650210
[TBL] [Abstract][Full Text] [Related]
2. Treatment and survival of patients harboring histological variants of glioblastoma.
Ortega A; Nuño M; Walia S; Mukherjee D; Black KL; Patil CG
J Clin Neurosci; 2014 Oct; 21(10):1709-13. PubMed ID: 24980627
[TBL] [Abstract][Full Text] [Related]
3. Adult gliosarcoma: epidemiology, natural history, and factors associated with outcome.
Kozak KR; Mahadevan A; Moody JS
Neuro Oncol; 2009 Apr; 11(2):183-91. PubMed ID: 18780813
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcome of gliosarcoma compared with glioblastoma multiforme: a clinical study in Chinese patients.
Zhang G; Huang S; Zhang J; Wu Z; Lin S; Wang Y
J Neurooncol; 2016 Apr; 127(2):355-62. PubMed ID: 26725096
[TBL] [Abstract][Full Text] [Related]
5. Clinical management and survival outcomes of gliosarcomas in the era of multimodality therapy.
Damodaran O; van Heerden J; Nowak AK; Bynevelt M; McDonald K; Marsh J; Lee G
J Clin Neurosci; 2014 Mar; 21(3):478-81. PubMed ID: 24332268
[TBL] [Abstract][Full Text] [Related]
6. Epidemiologic Features, Survival, and Prognostic Factors Among Patients With Different Histologic Variants of Glioblastoma: Analysis of a Nationwide Database.
Shieh LT; Ho CH; Guo HR; Huang CC; Ho YC; Ho SY
Front Neurol; 2021; 12():659921. PubMed ID: 34899553
[No Abstract] [Full Text] [Related]
7. Gliosarcoma: a clinical and radiological analysis of 48 cases.
Yi X; Cao H; Tang H; Gong G; Hu Z; Liao W; Sun L; Chen BT; Li X
Eur Radiol; 2019 Jan; 29(1):429-438. PubMed ID: 29948068
[TBL] [Abstract][Full Text] [Related]
8. Gliosarcoma: The Distinct Genomic Alterations Identified by Comprehensive Analysis of Copy Number Variations.
Cheng CD; Chen C; Wang L; Dong YF; Yang Y; Chen YN; Niu WX; Wang WC; Liu QS; Niu CS
Anal Cell Pathol (Amst); 2022; 2022():2376288. PubMed ID: 35757013
[TBL] [Abstract][Full Text] [Related]
9. Radiotherapy plus concomitant temozolomide in primary gliosarcoma.
Adeberg S; Bernhardt D; Harrabi SB; Diehl C; Koelsche C; Rieken S; Unterberg A; von Deimling A; Debus J
J Neurooncol; 2016 Jun; 128(2):341-8. PubMed ID: 27025857
[TBL] [Abstract][Full Text] [Related]
10. An individual patient data meta-analysis on characteristics, treatments and outcomes of glioblastoma/ gliosarcoma patients with metastases outside of the central nervous system.
Pietschmann S; von Bueren AO; Kerber MJ; Baumert BG; Kortmann RD; Müller K
PLoS One; 2015; 10(4):e0121592. PubMed ID: 25860797
[TBL] [Abstract][Full Text] [Related]
11. Racial/ethnic differences in survival for patients with gliosarcoma: an analysis of the National cancer database.
Wright JM; Hodges TR; Wright CH; Gittleman H; Zhou X; Duncan K; Kruchko C; Sloan A; Barnholtz-Sloan JS
J Neurooncol; 2019 Jun; 143(2):349-357. PubMed ID: 30989622
[TBL] [Abstract][Full Text] [Related]
12. Secondary gliosarcoma: the clinicopathological features and the development of a patient-derived xenograft model of gliosarcoma.
Kiang KM; Chan AA; Leung GK
BMC Cancer; 2021 Mar; 21(1):265. PubMed ID: 33706745
[TBL] [Abstract][Full Text] [Related]
13. Prognosis and management of gliosarcoma patients: A review of literature.
Saadeh F; El Iskandarani S; Najjar M; Assi HI
Clin Neurol Neurosurg; 2019 Jul; 182():98-103. PubMed ID: 31112812
[TBL] [Abstract][Full Text] [Related]
14. Incidence, survival, pathology, and genetics of adult Latino Americans with glioblastoma.
Shabihkhani M; Telesca D; Movassaghi M; Naeini YB; Naeini KM; Hojat SA; Gupta D; Lucey GM; Ontiveros M; Wang MW; Hanna LS; Sanchez DE; Mareninov S; Khanlou N; Vinters HV; Bergsneider M; Nghiemphu PL; Lai A; Liau LM; Cloughesy TF; Yong WH
J Neurooncol; 2017 Apr; 132(2):351-358. PubMed ID: 28161760
[TBL] [Abstract][Full Text] [Related]
15. Secondary gliosarcoma after diagnosis of glioblastoma: clinical experience with 30 consecutive patients.
Han SJ; Yang I; Otero JJ; Ahn BJ; Tihan T; McDermott MW; Berger MS; Chang SM; Parsa AT
J Neurosurg; 2010 May; 112(5):990-6. PubMed ID: 19817543
[TBL] [Abstract][Full Text] [Related]
16. Epidemiologic and molecular prognostic review of glioblastoma.
Thakkar JP; Dolecek TA; Horbinski C; Ostrom QT; Lightner DD; Barnholtz-Sloan JS; Villano JL
Cancer Epidemiol Biomarkers Prev; 2014 Oct; 23(10):1985-96. PubMed ID: 25053711
[TBL] [Abstract][Full Text] [Related]
17. Treatments of gliosarcoma of the brain: a systematic review and meta-analysis.
Wang X; Jiang J; Liu M; You C
Acta Neurol Belg; 2021 Dec; 121(6):1789-1797. PubMed ID: 33156945
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcome of gliosarcoma compared with glioblastoma multiforme: North Central Cancer Treatment Group results.
Galanis E; Buckner JC; Dinapoli RP; Scheithauer BW; Jenkins RB; Wang CH; O'Fallon JR; Farr G
J Neurosurg; 1998 Sep; 89(3):425-30. PubMed ID: 9724117
[TBL] [Abstract][Full Text] [Related]
19. Giant cell glioblastoma: a glioblastoma subtype with distinct epidemiology and superior prognosis.
Kozak KR; Moody JS
Neuro Oncol; 2009 Dec; 11(6):833-41. PubMed ID: 19332771
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors and clinical outcomes in adult primary gliosarcoma patients: a Surveillance, Epidemiology, and End Results (SEER) analysis from 2004 to 2015.
Huang Q; Li F; Chen Y; Hong F; Wang H; Chen J
Br J Neurosurg; 2020 Apr; 34(2):161-167. PubMed ID: 31829033
[No Abstract] [Full Text] [Related]
[Next] [New Search]
